Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant β-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2002-12, Vol.46 (12), p.3991-3994 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3994 |
|---|---|
| container_issue | 12 |
| container_start_page | 3991 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 46 |
| creator | MIRO, Elisenda NAVARRO, Ferran MIRELIS, Beatriz SABATE, Montserrat RIVERA, Alba COLL, Pere PRATS, Guillem |
| description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.46.12.3991-3994.2002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_12435708</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18535542</sourcerecordid><originalsourceid>FETCH-LOGICAL-a549t-b09f79db4e559283a9465a96d51515526bd3f839cb43d0ac6d7d0433f19722a43</originalsourceid><addsrcrecordid>eNqNkt-KEzEUxgdR3Lr6ChIEvdqp-T-TCy9qWd1CwaLuhVfhTCbTyTJNusm0sq_jI_ggPpMpLe56pQROSPL78p2ErygQwVNCaP12NptPuZwSOmVKkTIXPqUY00fFhGBVl1Io-biYYCxlyWvMz4pnKd3gvBYKPy3OCOVMVLieFD9W0e5hsN5YFDo0H5x3Bga0SGGA0abD5mUyvY3O9A6QCYNDqxjanXF-jRa-d40bQyw_2-TSCH5Ev36WSzAjbCBlPYwI0LV3exuTG-_QVUhbN2YH59F7iMYOwcMF-rIF5y9QyFjmWfnNQkSr7Bra58WTDoZkX5zm8-L6w-XX-VW5_PRxMZ8tSxBcjWWDVVeptuFWCEVrBopLAUq2guQhqGxa1tVMmYazFoORbdVizlhHVEUpcHZevDveu901G9sa68cIg95Gt4F4pwM4_feJd71eh70mjFYVyfo3J30MtzubRr1xKb9vAG_DLumKSkU4w_8ESS2YEJxmsD6CJoaUou3-NEOwPgRB5yBoLjWh-hCEQ-H6EIQsFUcppA3VN2EXff67_9G9fPgJ94anxGTg9QmAlIPSRfDGpXuOY1YLLDL36sj1bt1_d9Hq3IkGMA982W8OaNmh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18535542</pqid></control><display><type>article</type><title>Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant β-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>MIRO, Elisenda ; NAVARRO, Ferran ; MIRELIS, Beatriz ; SABATE, Montserrat ; RIVERA, Alba ; COLL, Pere ; PRATS, Guillem</creator><creatorcontrib>MIRO, Elisenda ; NAVARRO, Ferran ; MIRELIS, Beatriz ; SABATE, Montserrat ; RIVERA, Alba ; COLL, Pere ; PRATS, Guillem</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.46.12.3991-3994.2002</identifier><identifier>PMID: 12435708</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Amoxicillin-Potassium Clavulanate Combination ; Amoxicillin-Potassium Clavulanate Combination - pharmacology ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; beta-Lactamases ; beta-Lactamases - genetics ; Biological and medical sciences ; Drug Resistance, Bacterial - genetics ; Electrophoresis, Gel, Pulsed-Field ; Escherichia coli ; Escherichia coli - drug effects ; Escherichia coli - enzymology ; Escherichia coli - isolation & purification ; Humans ; Mechanisms of Resistance ; Medical sciences ; Microbial Sensitivity Tests ; Pharmacology. Drug treatments ; Phenotype ; Spain</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2002-12, Vol.46 (12), p.3991-3994</ispartof><rights>2003 INIST-CNRS</rights><rights>Copyright © 2002 American Society for Microbiology</rights><rights>Copyright © 2002, American Society for Microbiology 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a549t-b09f79db4e559283a9465a96d51515526bd3f839cb43d0ac6d7d0433f19722a43</citedby><cites>FETCH-LOGICAL-a549t-b09f79db4e559283a9465a96d51515526bd3f839cb43d0ac6d7d0433f19722a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC132771/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC132771/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,729,782,786,887,27931,27932,53798,53800</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14038505$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12435708$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MIRO, Elisenda</creatorcontrib><creatorcontrib>NAVARRO, Ferran</creatorcontrib><creatorcontrib>MIRELIS, Beatriz</creatorcontrib><creatorcontrib>SABATE, Montserrat</creatorcontrib><creatorcontrib>RIVERA, Alba</creatorcontrib><creatorcontrib>COLL, Pere</creatorcontrib><creatorcontrib>PRATS, Guillem</creatorcontrib><title>Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant β-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>AAC</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Amoxicillin-Potassium Clavulanate Combination</subject><subject>Amoxicillin-Potassium Clavulanate Combination - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>beta-Lactamases</subject><subject>beta-Lactamases - genetics</subject><subject>Biological and medical sciences</subject><subject>Drug Resistance, Bacterial - genetics</subject><subject>Electrophoresis, Gel, Pulsed-Field</subject><subject>Escherichia coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - enzymology</subject><subject>Escherichia coli - isolation & purification</subject><subject>Humans</subject><subject>Mechanisms of Resistance</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenotype</subject><subject>Spain</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkt-KEzEUxgdR3Lr6ChIEvdqp-T-TCy9qWd1CwaLuhVfhTCbTyTJNusm0sq_jI_ggPpMpLe56pQROSPL78p2ErygQwVNCaP12NptPuZwSOmVKkTIXPqUY00fFhGBVl1Io-biYYCxlyWvMz4pnKd3gvBYKPy3OCOVMVLieFD9W0e5hsN5YFDo0H5x3Bga0SGGA0abD5mUyvY3O9A6QCYNDqxjanXF-jRa-d40bQyw_2-TSCH5Ev36WSzAjbCBlPYwI0LV3exuTG-_QVUhbN2YH59F7iMYOwcMF-rIF5y9QyFjmWfnNQkSr7Bra58WTDoZkX5zm8-L6w-XX-VW5_PRxMZ8tSxBcjWWDVVeptuFWCEVrBopLAUq2guQhqGxa1tVMmYazFoORbdVizlhHVEUpcHZevDveu901G9sa68cIg95Gt4F4pwM4_feJd71eh70mjFYVyfo3J30MtzubRr1xKb9vAG_DLumKSkU4w_8ESS2YEJxmsD6CJoaUou3-NEOwPgRB5yBoLjWh-hCEQ-H6EIQsFUcppA3VN2EXff67_9G9fPgJ94anxGTg9QmAlIPSRfDGpXuOY1YLLDL36sj1bt1_d9Hq3IkGMA982W8OaNmh</recordid><startdate>20021201</startdate><enddate>20021201</enddate><creator>MIRO, Elisenda</creator><creator>NAVARRO, Ferran</creator><creator>MIRELIS, Beatriz</creator><creator>SABATE, Montserrat</creator><creator>RIVERA, Alba</creator><creator>COLL, Pere</creator><creator>PRATS, Guillem</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20021201</creationdate><title>Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant β-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period</title><author>MIRO, Elisenda ; NAVARRO, Ferran ; MIRELIS, Beatriz ; SABATE, Montserrat ; RIVERA, Alba ; COLL, Pere ; PRATS, Guillem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a549t-b09f79db4e559283a9465a96d51515526bd3f839cb43d0ac6d7d0433f19722a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Amoxicillin-Potassium Clavulanate Combination</topic><topic>Amoxicillin-Potassium Clavulanate Combination - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>beta-Lactamases</topic><topic>beta-Lactamases - genetics</topic><topic>Biological and medical sciences</topic><topic>Drug Resistance, Bacterial - genetics</topic><topic>Electrophoresis, Gel, Pulsed-Field</topic><topic>Escherichia coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - enzymology</topic><topic>Escherichia coli - isolation & purification</topic><topic>Humans</topic><topic>Mechanisms of Resistance</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenotype</topic><topic>Spain</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MIRO, Elisenda</creatorcontrib><creatorcontrib>NAVARRO, Ferran</creatorcontrib><creatorcontrib>MIRELIS, Beatriz</creatorcontrib><creatorcontrib>SABATE, Montserrat</creatorcontrib><creatorcontrib>RIVERA, Alba</creatorcontrib><creatorcontrib>COLL, Pere</creatorcontrib><creatorcontrib>PRATS, Guillem</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MIRO, Elisenda</au><au>NAVARRO, Ferran</au><au>MIRELIS, Beatriz</au><au>SABATE, Montserrat</au><au>RIVERA, Alba</au><au>COLL, Pere</au><au>PRATS, Guillem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant β-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>AAC</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2002-12-01</date><risdate>2002</risdate><volume>46</volume><issue>12</issue><spage>3991</spage><epage>3994</epage><pages>3991-3994</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>12435708</pmid><doi>10.1128/AAC.46.12.3991-3994.2002</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 2002-12, Vol.46 (12), p.3991-3994 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_pubmed_primary_12435708 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Amoxicillin-Potassium Clavulanate Combination Amoxicillin-Potassium Clavulanate Combination - pharmacology Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents beta-Lactamases beta-Lactamases - genetics Biological and medical sciences Drug Resistance, Bacterial - genetics Electrophoresis, Gel, Pulsed-Field Escherichia coli Escherichia coli - drug effects Escherichia coli - enzymology Escherichia coli - isolation & purification Humans Mechanisms of Resistance Medical sciences Microbial Sensitivity Tests Pharmacology. Drug treatments Phenotype Spain |
| title | Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant β-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T20%3A46%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Clinical%20Isolates%20of%20Escherichia%20coli%20Producing%20Inhibitor-Resistant%20%CE%B2-Lactamases%20at%20a%20University%20Hospital%20in%20Barcelona,%20Spain,%20over%20a%203-Year%20Period&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=MIRO,%20Elisenda&rft.date=2002-12-01&rft.volume=46&rft.issue=12&rft.spage=3991&rft.epage=3994&rft.pages=3991-3994&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.46.12.3991-3994.2002&rft_dat=%3Cproquest_pubme%3E18535542%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18535542&rft_id=info:pmid/12435708&rfr_iscdi=true |